Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Neal Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, discusses clinical research in advanced prostate cancer References and Resources Click Here to visit to the National Cancer…
Nicole Artz, MD, Assistant Professor of Medicine at the University of Chicago Hospital, discusses the increasing role of the internist in the management of patients with sickle cell…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University, provides an overview of the epidemiology and clinical progression of Hepatitis B. References and Resources Gish RG,…
Stephen Brunton, MD, Director of Faculty Development, Cabarrus Family Medicine, Charlotte, North Carolina, discusses the most recent U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence…
General Surgeon, Les Edrich, MD provides some insight toward negotiating the delicate balance of providing information, treatment options, and an opinion regarding the best course of treatment while…
